Skip to main content
. 2017 Jul 5;2017:6264146. doi: 10.1155/2017/6264146

Table 4.

Test statisticsa. aWilcoxon signed ranks test. bBased on positive ranks. cBased on negative ranks.

vas2w-vaspi Vas1m-vaspi Vas3m-vaspi Vas4m-vaspi Vas6m-vaspi

Z −4,390b −4,410b −4,395b −4,392b −4,124b
Asymp.Sig. (2-tailed) ,000 ,000 ,000 ,000 ,000

vas1m-vas2w vas3m-vas2w Vas4m-vas2w vas6m-vas2w

Z −3,257b −2,751b −1,629b −2,644c
Asymp.Sig. (2-tailed) ,001 ,006 ,103 ,008

vas3m-vas1m vas4m-vas1m vas6m-vas1m vas4m-vas3m

Z −,736c −2,656c −4,234c −2,762c
Asymp.Sig. (2-tailed) ,461 ,008 ,000 ,006

vas6m-vas3m Vas6m-vas4m

Z −4,148c −4,239c
Asymp.Sig. (2-tailed) ,000 ,000

vaspi: VAS score at preinjection; vas2w: VAS score at 2 weeks (after injection); vas1m: VAS score in first month; vas3m: VAS score in third month; vas4m: VAS score in fourth month; vas6m: VAS score in sixth month.